Table 3.
Characteristics of Sudden Infant Death Syndrome Reports in the Vaccine Adverse Event Reporting System, 1997–2013
| Characteristic | No. (%) |
|---|---|
| SIDS reports | 603 (28.1) |
| Male sexa | 375 (62.2) |
| Onset, d, median (range) | 3 (0–121) |
| Age, mo, median (range) Type of reporterb (n = 581) |
2 (0–37) |
| Provider | 340 (58.5) |
| Other | 171 (29.4) |
| Parent/patient | 37 (6.4) |
| Manufacturer | 33 (5.7) |
| Age group, mo (n = 603) | |
| <12 | 582 (96.5) |
| 12–48 | 20 (3.3) |
| Unknown | 1 (0.2) |
| No. of SIDS reports with autopsy reports and/or death certificate | 544 (90.2) |
| Top 4 vaccines given individually or simultaneously | |
| DTaP-HepB-IPV + Hib + PCV7 or PCV13 | 70 (11.6) |
| HepB | 54 (8.9) |
| DTaP + Hib-HepB + IPV + PCV7 or PCV13 | 52 (8.6) |
| DTaP + Hep B + Hib + IPV | 47 (7.8) |
| DTaP + Hib + IPV + PCV7 or PCV13 | 42 (6.9) |
Total death reports = 2149.
Abbreviations: DTaP, diphtheria, tetanus, and acellular pertussis vaccine; DTaP-IPV-Hib, combination diphtheria, tetanus, and acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type b conjugate vaccine; HepB, hepatitis B vaccine; Hib, Haemophilus influenzae type b conjugate vaccine; Hib-HepB, combination Haemophilus influenzae type b conjugate and hepatitis B vaccine; IPV, inactivated poliovirus vaccine; PCV7, 7-valent pneumococcal conjugate vaccine; PCV13, 13-valent pneumococcal conjugate vaccine; SIDS, sudden infant death syndrome.
Sex unknown in 2 reports.
Type of reporter unknown for 22 reports.